CorMedix, Inc. (CRMD)
6.55
+0.10
(+1.55%)
USD |
NASDAQ |
Mar 16, 16:00
6.55
0.00 (0.00%)
After-Hours: 18:18
CorMedix EPS Diluted (Quarterly) : 0.1493 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Amicus Therapeutics, Inc. | 0.0054 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| Castle Biosciences, Inc. | -0.0795 |
| Indivior Pharmaceuticals, Inc. | 0.816 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.02M |
| Revenue (Quarterly) | 128.62M |
| Total Expenses (Quarterly) | 114.60M |
| Enterprise Value | 509.60M |
| Gross Profit Margin (Quarterly) | 83.43% |
| Profit Margin (Quarterly) | 10.90% |
| Earnings Yield | 30.28% |
| Operating Earnings Yield | 28.56% |
| Normalized Earnings Yield | 30.40 |